Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting
US6194211A · kind A · utility
18Cited by
1References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 16, 1996 |
| Grant date | Feb 27, 2001 |
| Priority date | — |
| Expiry date | May 16, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N15/85
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The transcriptional regulatory sequence (TRS) of Carcinoembryonic Antigen (CEA) and molecular chimeras comprising the CEA TRS and DNA encoding a heterologous enzyme are described. Such molecular chimeras are capable of targeting the expression of the heterologous enzyme to CEA-positive cells. The heterologous enzyme may be cytosine deaminase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.